4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide

C164H188N24O12 — CID 158726481

IUPAC4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide
SMILESCC1CCC(NC(=O)c2ccc(-c3nc4ccc(NC(=O)C56CC7CC(CC(C7)C5)C6)cc4[nH]3)cc2)CC1.CC1CCC(NC(=O)c2ccc(-c3nc4ccc(NC(=O)C5CCCCC5)cc4[nH]3)cc2)CC1.CNC(=O)c1ccc(-c2nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3[nH]2)cc1.CNC(=O)c1ccc(-c2nc3ccc(NC(=O)C4CCCCC4)cc3[nH]2)cc1.O=C(NC1CCCC1)c1ccc(-c2nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3[nH]2)cc1.O=C(NC1CCCC1)c1ccc(-c2nc3ccc(NC(=O)C4CCCCC4)cc3[nH]2)cc1
InChIInChI=1S/C32H38N4O2.C30H34N4O2.C28H34N4O2.C26H28N4O2.C26H30N4O2.C22H24N4O2/c1-19-2-8-25(9-3-19)33-30(37)24-6-4-23(5-7-24)29-35-27-11-10-26(15-28(27)36-29)34-31(38)32-16-20-12-21(17-32)14-22(13-20)18-32;35-28(31-23-3-1-2-4-23)22-7-5-21(6-8-22)27-33-25-10-9-24(14-26(25)34-27)32-29(36)30-15-18-11-19(16-30)13-20(12-18)17-30;1-18-7-13-22(14-8-18)29-28(34)21-11-9-19(10-12-21)26-31-24-16-15-23(17-25(24)32-26)30-27(33)20-5-3-2-4-6-20;1-27-24(31)19-4-2-18(3-5-19)23-29-21-7-6-20(11-22(21)30-23)28-25(32)26-12-15-8-16(13-26)10-17(9-15)14-26;31-25(18-6-2-1-3-7-18)28-21-14-15-22-23(16-21)30-24(29-22)17-10-12-19(13-11-17)26(32)27-20-8-4-5-9-20;1-23-21(27)16-9-7-14(8-10-16)20-25-18-12-11-17(13-19(18)26-20)24-22(28)15-5-3-2-4-6-15/h4-7,10-11,15,19-22,25H,2-3,8-9,12-14,16-18H2,1H3,(H,33,37)(H,34,38)(H,35,36);5-10,14,18-20,23H,1-4,11-13,15-17H2,(H,31,35)(H,32,36)(H,33,34);9-12,15-18,20,22H,2-8,13-14H2,1H3,(H,29,34)(H,30,33)(H,31,32);2-7,11,15-17H,8-10,12-14H2,1H3,(H,27,31)(H,28,32)(H,29,30);10-16,18,20H,1-9H2,(H,27,32)(H,28,31)(H,29,30);7-13,15H,2-6H2,1H3,(H,23,27)(H,24,28)(H,25,26)
InChIKeyIKOHDILHFNKVPT-UHFFFAOYSA-N
MW2687.46 g/mol
LogP33.08
Rot. Bonds28

About 4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide

4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide (PubChem CID 158726481) has the molecular formula C164H188N24O12 and a molecular weight of 2687.46 g/mol. Its IUPAC name is 4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide.

Molecular Properties

Compound Name4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide
PubChem CID158726481
Molecular FormulaC164H188N24O12
Molecular Weight2687.46 g/mol
Exact Mass2685.48
IUPAC Name4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide
SMILESCC1CCC(NC(=O)c2ccc(-c3nc4ccc(NC(=O)C56CC7CC(CC(C7)C5)C6)cc4[nH]3)cc2)CC1.CC1CCC(NC(=O)c2ccc(-c3nc4ccc(NC(=O)C5CCCCC5)cc4[nH]3)cc2)CC1.CNC(=O)c1ccc(-c2nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3[nH]2)cc1.CNC(=O)c1ccc(-c2nc3ccc(NC(=O)C4CCCCC4)cc3[nH]2)cc1.O=C(NC1CCCC1)c1ccc(-c2nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3[nH]2)cc1.O=C(NC1CCCC1)c1ccc(-c2nc3ccc(NC(=O)C4CCCCC4)cc3[nH]2)cc1
InChIInChI=1S/C32H38N4O2.C30H34N4O2.C28H34N4O2.C26H28N4O2.C26H30N4O2.C22H24N4O2/c1-19-2-8-25(9-3-19)33-30(37)24-6-4-23(5-7-24)29-35-27-11-10-26(15-28(27)36-29)34-31(38)32-16-20-12-21(17-32)14-22(13-20)18-32;35-28(31-23-3-1-2-4-23)22-7-5-21(6-8-22)27-33-25-10-9-24(14-26(25)34-27)32-29(36)30-15-18-11-19(16-30)13-20(12-18)17-30;1-18-7-13-22(14-8-18)29-28(34)21-11-9-19(10-12-21)26-31-24-16-15-23(17-25(24)32-26)30-27(33)20-5-3-2-4-6-20;1-27-24(31)19-4-2-18(3-5-19)23-29-21-7-6-20(11-22(21)30-23)28-25(32)26-12-15-8-16(13-26)10-17(9-15)14-26;31-25(18-6-2-1-3-7-18)28-21-14-15-22-23(16-21)30-24(29-22)17-10-12-19(13-11-17)26(32)27-20-8-4-5-9-20;1-23-21(27)16-9-7-14(8-10-16)20-25-18-12-11-17(13-19(18)26-20)24-22(28)15-5-3-2-4-6-15/h4-7,10-11,15,19-22,25H,2-3,8-9,12-14,16-18H2,1H3,(H,33,37)(H,34,38)(H,35,36);5-10,14,18-20,23H,1-4,11-13,15-17H2,(H,31,35)(H,32,36)(H,33,34);9-12,15-18,20,22H,2-8,13-14H2,1H3,(H,29,34)(H,30,33)(H,31,32);2-7,11,15-17H,8-10,12-14H2,1H3,(H,27,31)(H,28,32)(H,29,30);10-16,18,20H,1-9H2,(H,27,32)(H,28,31)(H,29,30);7-13,15H,2-6H2,1H3,(H,23,27)(H,24,28)(H,25,26)
InChIKeyIKOHDILHFNKVPT-UHFFFAOYSA-N
XLogP33.08
TPSA521.28 Ų
H-Bond Donors18
H-Bond Acceptors18
Rotatable Bonds28
Heavy Atoms200
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002687.46
LogP ≤ 533.08
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1018

Analyze 4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-cyclooctyl-4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]benzamide
CID 142169240
N-[2-[4-(3-bicyclo[4.2.0]octanylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide
CID 71169778
4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclohexylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclohexylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclohexylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(2-methylcyclohexyl)benzamide;N-[2-[4-(cyclohexylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(cyclohexylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide;N-[2-[4-(cyclohexylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-cyclohexyl-4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]benzamide;N-cyclohexyl-4-[6-[(2-methylcyclohexanecarbonyl)amino]-1H-benzimidazol-2-yl]benzamide;N-cyclohexyl-4-[6-[(4-methylcyclohexanecarbonyl)amino]-1H-benzimidazol-2-yl]benzamide;3,4-dichloro-N-[2-[4-(cyclohexylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide;N-[2-[4-[(2-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide
CID 159497338
2-[4-(adamantane-1-carbonylamino)phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-(4-benzamidophenyl)-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-[4-[(4-chlorobenzoyl)amino]phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexanecarbonylamino)phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;2-[4-(cyclopentanecarbonylamino)phenyl]-N-cyclopentyl-3H-benzimidazole-5-carboxamide;N-cyclopentyl-2-[4-[(4-fluorobenzoyl)amino]phenyl]-3H-benzimidazole-5-carboxamide;N-cyclopentyl-2-[4-[(4-methoxybenzoyl)amino]phenyl]-3H-benzimidazole-5-carboxamide
CID 160535939
4-[6-[(2-methylcyclohexanecarbonyl)amino]-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide
CID 10183841
N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclohexanecarboxamide;N-[4-(6-acetamido-1H-benzimidazol-2-yl)phenyl]cyclopentanecarboxamide;N-[2-[4-(cyclohexanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide;N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;bis(N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide);N-[2-[4-(cyclopentanecarbonylamino)phenyl]-3H-benzimidazol-5-yl]cycloheptanecarboxamide
CID 160657271
4-[6-[(2-ethylcyclohexanecarbonyl)amino]-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide
CID 71172829
N-[2-[4-(1-adamantylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide
CID 11318815
4-(6-benzamido-1H-benzimidazol-2-yl)-N-(4-methylcyclohexyl)benzamide
CID 20740000
N-[2-[4-(cycloheptylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]bicyclo[2.2.1]heptane-2-carboxamide
CID 10276939
2-[4-(adamantane-1-carbonylamino)phenyl]-N-pyridin-2-yl-3H-benzimidazole-5-carboxamide;2-(4-benzamidophenyl)-N-pyridin-2-yl-3H-benzimidazole-5-carboxamide;2-[4-[(4-chlorobenzoyl)amino]phenyl]-N-pyridin-2-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclohexanecarbonylamino)phenyl]-N-pyridin-2-yl-3H-benzimidazole-5-carboxamide;2-[4-(cyclopentanecarbonylamino)phenyl]-N-pyridin-2-yl-3H-benzimidazole-5-carboxamide
CID 161005892
N-(2-bicyclo[2.2.1]heptanyl)-4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]benzamide
CID 20740008

Frequently Asked Questions

What is the IUPAC name of 4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide?
The IUPAC name of 4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide (CID 158726481) is 4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide.
What is the SMILES notation for 4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide?
The canonical SMILES for 4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide is CC1CCC(NC(=O)c2ccc(-c3nc4ccc(NC(=O)C56CC7CC(CC(C7)C5)C6)cc4[nH]3)cc2)CC1.CC1CCC(NC(=O)c2ccc(-c3nc4ccc(NC(=O)C5CCCCC5)cc4[nH]3)cc2)CC1.CNC(=O)c1ccc(-c2nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3[nH]2)cc1.CNC(=O)c1ccc(-c2nc3ccc(NC(=O)C4CCCCC4)cc3[nH]2)cc1.O=C(NC1CCCC1)c1ccc(-c2nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3[nH]2)cc1.O=C(NC1CCCC1)c1ccc(-c2nc3ccc(NC(=O)C4CCCCC4)cc3[nH]2)cc1.
What is the InChIKey of 4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide?
The InChIKey is IKOHDILHFNKVPT-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H38N4O2.C30H34N4O2.C28H34N4O2.C26H28N4O2.C26H30N4O2.C22H24N4O2/c1-19-2-8-25(9-3-19)33-30(37)24-6-4-23(5-7-24)29-35-27-11-10-26(15-28(27)36-29)34-31(38)32-16-20-12-21(17-32)14-22(13-20)18-32;35-28(31-23-3-1-2-4-23)22-7-5-21(6-8-22)27-33-25-10-9-24(14-26(25)34-27)32-29(36)30-15-18-11-19(16-30)13-20(12-18)17-30;1-18-7-13-22(14-8-18)29-28(34)21-11-9-19(10-12-21)26-31-24-16-15-23(17-25(24)32-26)30-27(33)20-5-3-2-4-6-20;1-27-24(31)19-4-2-18(3-5-19)23-29-21-7-6-20(11-22(21)30-23)28-25(32)26-12-15-8-16(13-26)10-17(9-15)14-26;31-25(18-6-2-1-3-7-18)28-21-14-15-22-23(16-21)30-24(29-22)17-10-12-19(13-11-17)26(32)27-20-8-4-5-9-20;1-23-21(27)16-9-7-14(8-10-16)20-25-18-12-11-17(13-19(18)26-20)24-22(28)15-5-3-2-4-6-15/h4-7,10-11,15,19-22,25H,2-3,8-9,12-14,16-18H2,1H3,(H,33,37)(H,34,38)(H,35,36);5-10,14,18-20,23H,1-4,11-13,15-17H2,(H,31,35)(H,32,36)(H,33,34);9-12,15-18,20,22H,2-8,13-14H2,1H3,(H,29,34)(H,30,33)(H,31,32);2-7,11,15-17H,8-10,12-14H2,1H3,(H,27,31)(H,28,32)(H,29,30);10-16,18,20H,1-9H2,(H,27,32)(H,28,31)(H,29,30);7-13,15H,2-6H2,1H3,(H,23,27)(H,24,28)(H,25,26).
What are the key properties of 4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide?
4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide has a molecular weight of 2687.46 g/mol, XLogP of 33.08, 28 rotatable bonds, 18 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]-N-(4-methylcyclohexyl)benzamide;N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-(methylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide;N-[2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazol-5-yl]adamantane-1-carboxamide is sourced from PubChem (CID 158726481), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).